LDC and Boehringer Ingelheim join forces to discover schizophrenia treatment
11 May 2016 | By Victoria White, Digital Content Producer
Boehringer Ingelheim will have the option of exclusive rights to a new compound for the treatment of schizophrenia to be discovered and developed at the LDC...